The city of Fort Lauderdale, Florida, currently has 1 active clinical trials seeking participants for Alzheimer's Disease research studies.
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Recruiting
The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).
Gender:
All
Ages:
Between 50 years and 85 years
Trial Updated:
03/04/2024
Locations: Broward Health Medical Center & The University of Florida, Fort Lauderdale, Florida
Conditions: Alzheimer Disease